182 related articles for article (PubMed ID: 25997246)
1. RIP-V improves murine survival in a sepsis model by down-regulating RNAIII expression and α-hemolysin release of methicillin-resistant Staphylococcus aureus.
Ma B; Zhou Y; Li M; Yu Q; Xue X; Li Z; Da F; Hou Z; Luo X
Pharmazie; 2015 Feb; 70(2):81-7. PubMed ID: 25997246
[TBL] [Abstract][Full Text] [Related]
2. RNAIII-inhibiting peptide improves efficacy of clinically used antibiotics in a murine model of staphylococcal sepsis.
Giacometti A; Cirioni O; Ghiselli R; Dell'Acqua G; Orlando F; D'Amato G; Mocchegiani F; Silvestri C; Del Prete MS; Rocchi M; Balaban N; Saba V; Scalise G
Peptides; 2005 Feb; 26(2):169-75. PubMed ID: 15629527
[TBL] [Abstract][Full Text] [Related]
3. Treatment efficacy of the lead RNAIII-inhibiting peptide YSPWTNF-NH2 in acquired Staphylococcus aureus sepsis: a histopathological assessment.
Ribeiro PD; Ribeiro OD; Marcolan AM; Medina-Acosta E
Peptides; 2003 Nov; 24(11):1829-36. PubMed ID: 15019216
[TBL] [Abstract][Full Text] [Related]
4. Oligomerization of RNAIII-Inhibiting Peptide Inhibits Adherence and Biofilm Formation of Methicillin-Resistant Staphylococcus aureus In Vitro and In Vivo.
Zhou Y; Zhao R; Ma B; Gao H; Xue X; Qu D; Li M; Meng J; Luo X; Hou Z
Microb Drug Resist; 2016 Apr; 22(3):193-201. PubMed ID: 26571297
[TBL] [Abstract][Full Text] [Related]
5. Artesunate in combination with oxacillin protect sepsis model mice challenged with lethal live methicillin-resistant Staphylococcus aureus (MRSA) via its inhibition on proinflammatory cytokines release and enhancement on antibacterial activity of oxacillin.
Jiang W; Li B; Zheng X; Liu X; Cen Y; Li J; Pan X; Cao H; Zheng J; Zhou H
Int Immunopharmacol; 2011 Aug; 11(8):1065-73. PubMed ID: 21396483
[TBL] [Abstract][Full Text] [Related]
6. RNAIII-inhibiting peptide in combination with the cathelicidin BMAP-28 reduces lethality in mouse models of staphylococcal sepsis.
Ghiselli R; Giacometti A; Cirioni O; Dell'Acqua G; Bergnach C; Orlando F; Mocchegiani F; Silvestri C; Skerlavaj B; Licci A; Balaban N; Zanetti M; Scalise G; Saba V
Shock; 2006 Sep; 26(3):296-301. PubMed ID: 16912656
[TBL] [Abstract][Full Text] [Related]
7. Discovery of a quorum-sensing inhibitor of drug-resistant staphylococcal infections by structure-based virtual screening.
Kiran MD; Adikesavan NV; Cirioni O; Giacometti A; Silvestri C; Scalise G; Ghiselli R; Saba V; Orlando F; Shoham M; Balaban N
Mol Pharmacol; 2008 May; 73(5):1578-86. PubMed ID: 18314496
[TBL] [Abstract][Full Text] [Related]
8. Effect of granulocyte colony-stimulating factor in experimental methicillin resistant Staphylococcus aureus sepsis.
Alp E; Gozukucuk S; Canoz O; Kirmaci B; Doganay M
BMC Infect Dis; 2004 Oct; 4():43. PubMed ID: 15491501
[TBL] [Abstract][Full Text] [Related]
9. α-Hemolysin, not Panton-Valentine leukocidin, impacts rabbit mortality from severe sepsis with methicillin-resistant Staphylococcus aureus osteomyelitis.
Crémieux AC; Saleh-Mghir A; Danel C; Couzon F; Dumitrescu O; Lilin T; Perronne C; Etienne J; Lina G; Vandenesch F
J Infect Dis; 2014 Jun; 209(11):1773-80. PubMed ID: 24376272
[TBL] [Abstract][Full Text] [Related]
10. Suppression of drug-resistant Staphylococcal Infections by the quorum-sensing inhibitor RNAIII-inhibiting peptide.
Dell'Acqua G; Giacometti A; Cirioni O; Ghiselli R; Saba V; Scalise G; Gov Y; Balaban N
J Infect Dis; 2004 Jul; 190(2):318-20. PubMed ID: 15216467
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and pharmacological evaluations of 4-hydroxycoumarin derivatives as a new class of anti-Staphylococcus aureus agents.
Li ZP; Li J; Qu D; Hou Z; Yang XH; Zhang ZD; Wang YK; Luo XX; Li MK
J Pharm Pharmacol; 2015 Apr; 67(4):573-82. PubMed ID: 25556550
[TBL] [Abstract][Full Text] [Related]
12. RNAIII-inhibiting peptide enhances healing of wounds infected with methicillin-resistant Staphylococcus aureus.
Simonetti O; Cirioni O; Ghiselli R; Goteri G; Scalise A; Orlando F; Silvestri C; Riva A; Saba V; Madanahally KD; Offidani A; Balaban N; Scalise G; Giacometti A
Antimicrob Agents Chemother; 2008 Jun; 52(6):2205-11. PubMed ID: 18391046
[TBL] [Abstract][Full Text] [Related]
13. Redeploying β-Lactam Antibiotics as a Novel Antivirulence Strategy for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections.
Waters EM; Rudkin JK; Coughlan S; Clair GC; Adkins JN; Gore S; Xia G; Black NS; Downing T; O'Neill E; Kadioglu A; O'Gara JP
J Infect Dis; 2017 Jan; 215(1):80-87. PubMed ID: 28077586
[TBL] [Abstract][Full Text] [Related]
14. Biochanin A as an α-hemolysin inhibitor for combating methicillin-resistant Staphylococcus aureus infection.
Feng J; Sun D; Wang L; Li X; Guan J; Wei L; Yue D; Wang X; Zhao Y; Yang H; Song W; Wang B
World J Microbiol Biotechnol; 2021 Nov; 38(1):6. PubMed ID: 34837116
[TBL] [Abstract][Full Text] [Related]
15. RNAIII-inhibiting peptide significantly reduces bacterial load and enhances the effect of antibiotics in the treatment of central venous catheter-associated Staphylococcus aureus infections.
Cirioni O; Giacometti A; Ghiselli R; Dell'Acqua G; Orlando F; Mocchegiani F; Silvestri C; Licci A; Saba V; Scalise G; Balaban N
J Infect Dis; 2006 Jan; 193(2):180-6. PubMed ID: 16362881
[TBL] [Abstract][Full Text] [Related]
16. Monoclonal Antibody Targeting Staphylococcus aureus Surface Protein A (SasA) Protect Against Staphylococcus aureus Sepsis and Peritonitis in Mice.
Yang Y; Qian M; Yi S; Liu S; Li B; Yu R; Guo Q; Zhang X; Yu C; Li J; Xu J; Chen W
PLoS One; 2016; 11(2):e0149460. PubMed ID: 26926145
[TBL] [Abstract][Full Text] [Related]
17. Housefly Phormicin inhibits Staphylococcus aureus and MRSA by disrupting biofilm formation and altering gene expression in vitro and in vivo.
Wang B; Yao Y; Wei P; Song C; Wan S; Yang S; Zhu GM; Liu HM
Int J Biol Macromol; 2021 Jan; 167():1424-1434. PubMed ID: 33202277
[TBL] [Abstract][Full Text] [Related]
18. α-Hemolysin activity of methicillin-susceptible Staphylococcus aureus predicts ventilator-associated pneumonia.
Stulik L; Malafa S; Hudcova J; Rouha H; Henics BZ; Craven DE; Sonnevend AM; Nagy E
Am J Respir Crit Care Med; 2014 Nov; 190(10):1139-48. PubMed ID: 25303310
[TBL] [Abstract][Full Text] [Related]
19. RNAIII Inhibiting Peptide (RIP) and Derivatives as Potential Tools for the Treatment of S. aureus Biofilm Infections.
Ciulla M; Di Stefano A; Marinelli L; Cacciatore I; Di Biase G
Curr Top Med Chem; 2018; 18(24):2068-2079. PubMed ID: 30345922
[TBL] [Abstract][Full Text] [Related]
20. Inhibiting PSMα-induced neutrophil necroptosis protects mice with MRSA pneumonia by blocking the agr system.
Zhou Y; Niu C; Ma B; Xue X; Li Z; Chen Z; Li F; Zhou S; Luo X; Hou Z
Cell Death Dis; 2018 Mar; 9(3):362. PubMed ID: 29500427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
